Leaked Memo Resurfaces: Pharma’s April Plot to Oust RFK Jr. from HHS

A resurfaced leaked memo from the Biotechnology Innovation Organization (BIO), first revealed by Brownstone Institute, April 2025, details a $2 million campaign to lobby Congress for Robert F. Kennedy Jr.’s removal as HHS Secretary, highlighting Big Pharma’s ongoing desperation amid his MAHA reforms.

As Kennedy’s regulatory push intensifies, this old plot—now recirculated by Malone—exposes the industry’s fear of accountability, blending fear-mongering and surrogate influence in a bid to preserve profits over public health.

Why it matters: This memo underscores Big Pharma’s corrupt grip on health policy, where billions in vaccine profits clash with Kennedy’s drive for transparency and safety—threatening to unravel a system built on shortcuts and suppression, even as reforms gain momentum.

The revelation flows into the latest developments, showing how industry panic persists despite months of pushback.

Driving the news: Dr. Malone reposted the memo on X, reigniting scrutiny of BIO’s strategy to “go to The Hill and lobby that it is time for RFK Jr to go,” amid Kennedy’s ongoing reforms at HHS.

• BIO allocated $2 million for the “Why We Vaccinate” campaign, using “inspire and frighten” tactics to manipulate public and legislative sentiment.
• The plan involves surrogates like Dr. Mehmet Oz and Sen. Bill Cassidy to provide bipartisan cover without engaging Kennedy directly.
• Investors are fleeing the sector due to Kennedy’s “unpredictability,” prompting BIO to commit half its reserves to neutralize him.

These details transition into the background, reminding readers of the memo’s origins.

Catch up quick: The memo, from BIO’s April 3, 2025, Vaccine Policy Steering Committee meeting, was first detailed in Malone’s Substack essay “The Plot to Get RFK, Jr.,” where he analyzed it as a “coup attempt against regulatory reform.” Kennedy’s MAHA agenda, including long-term vaccine data and liability restoration, has rattled BIO members like Pfizer, leading to this resurfaced plot amid ongoing congressional battles.

This context leads into the surprising elements that keep the story alive.

The intrigue: Despite being old news, Malone’s recirculation highlights BIO’s failure to oust Kennedy by September, as reforms like stricter FDA approvals continue, exposing the industry’s miscalculation in underestimating public support for MAHA.

This hidden failure segues into the deeper subtext of power struggles.

Between the lines: BIO’s avoidance of direct debate and reliance on narrative laundering—reframing “efficiency” as fewer safety checks—reveals a fragile system terrified of real science, mirroring global efforts like WHO treaties that erode sovereignty while protecting pharma profits.

These underlying dynamics naturally flow into voices from key figures.

What they’re saying:

• “A detailed secret trade-association memo plotting the removal of US Secretary of Health and Human Services Robert F. Kennedy, Jr. has leaked. It reads like a coup attempt against regulatory reform—and they are spending millions to make sure Kennedy is out of office by September,” Dr. Robert Malone wrote on X, reposting the April memo to highlight ongoing industry sabotage.
• In his full Substack post, Malone embeds the memo and warns, “This is not a war against misinformation. It’s a war against public transparency in science,” emphasizing BIO’s fear of Kennedy’s reforms exposing their “marketing for medicine” model.

These quotes capture the outrage, leading to the article’s conclusive takeaway.

The bottom line: As Kennedy weathers the storm with MAHA gaining ground—evidenced by recent FDA delays on rushed approvals and growing congressional support—the resurfaced memo may backfire, rallying more allies against Big Pharma’s tactics and accelerating demands for true health reform in a post-trust era.

The post Leaked Memo Resurfaces: Pharma’s April Plot to Oust RFK Jr. from HHS appeared first on National File.